Invitrogen Completes Acquisition of Dynal

Invitrogen Corporation announced that it has completed its acquisition of Dynal Biotech. Invitrogen acquired Dynal from majority owner Nordic Capital and a co-investor in a cash transaction totaling approximately 2.5 billion NOK, or approximately $391 million, based on foreign currency forward contracts executed previously by Invitrogen.

Yahoo News (http://biz.yahoo.com/bw/050401/15156.html?.v=1)